In this video, Sarah E. Hoffe, MD, of the Moffitt Cancer Center in Tampa, Florida, discusses the evolution of stereotactic body radiation therapy (SBRT) for the treatment of pancreatic cancer.
Hoffe also highlights a recent study published in Lancet Oncology using a genomic-adjusted radiation dose (GARD) in patients with various malignancies, a method that could individualize radiotherapy treatment. Watch here . . .